Renowned global leaders will guide scientific strategy in Parkinson’s disease and beyond as company enters clinical ...

Parkinson's disease represents a $6-8 billion market today, projected to exceed $13 billion by the 2030s, driven by rising ...

A new study reveals five mechanisms by which microplastics can trigger inflammation and cause damage in the brain.

Center, an ultra-high-performance brain-dedicated scanner called the NeuroEXPLORER (NX) is redefining what is possible in ...

Results support the potential of PMN310 to improve outcomes by selectively targeting oligomers and avoiding binding to monomer and plaque ProMIS ...

Microplastics are increasingly linked to brain inflammation and possible acceleration of Alzheimer’s and Parkinson’s, prompting scientists to call for reduced plastic use and stronger environmental ...

Cell death triggered by GPX4 loss was slowed in cell cultures and in mouse model using compounds that specifically inhibit ferroptosis.

Innovative outcome measures coupled with a focus on patient-centered clinical differentiation can help the biopharma industry ...

Aging is the primary risk factor for a spectrum of chronic conditions, yet we often study these diseases in isolation. A hallmark of the aging process is ...

This article explores how the role of regulatory T cells in immunological self-tolerance evolved from skepticism to Nobel ...

Neel Somani, a researcher specializing in mathematics, computer science, and business, has long explored the intersection ...